Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523321001121 |